FdaApplication

ANDA 216492

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRUBICON RESEARCH LTD
application_typeANDA
approval_date2023-01-18

Products (1)

ProductActive ingredientStrengthDosage form
GABAPENTINGABAPENTIN250MG/5MLSOLUTION;ORAL

1 product